The Cooper Companies, Inc. $COO Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 15.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,190,534 shares of the medical device company’s stock after selling 594,374 shares during the period. Alliancebernstein L.P. owned about 1.60% of Cooper Companies worth $218,743,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. CYBER HORNET ETFs LLC acquired a new stake in shares of Cooper Companies during the second quarter valued at about $36,000. MUFG Securities EMEA plc acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at about $42,000. Quent Capital LLC acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at about $44,000. Mather Group LLC. acquired a new position in shares of Cooper Companies in the 3rd quarter worth approximately $56,000. Finally, Federated Hermes Inc. bought a new stake in shares of Cooper Companies in the 3rd quarter valued at approximately $58,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Maria Rivas acquired 1,000 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were purchased at an average cost of $82.13 per share, with a total value of $82,130.00. Following the completion of the transaction, the director owned 11,141 shares of the company’s stock, valued at approximately $915,010.33. This trade represents a 9.86% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the transaction, the director directly owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This represents a 34.62% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 4,784 shares of company stock worth $397,093. 2.08% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have weighed in on COO shares. Morgan Stanley boosted their target price on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. Wells Fargo & Company boosted their price objective on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. Barclays upped their price objective on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a report on Friday, December 5th. Finally, William Blair raised Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Price Performance

NASDAQ COO opened at $71.04 on Tuesday. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $89.83. The stock has a market capitalization of $13.86 billion, a P/E ratio of 35.17, a P/E/G ratio of 1.80 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The business’s fifty day moving average is $80.99 and its two-hundred day moving average is $76.01.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the company posted $0.92 EPS. Cooper Companies’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.